OBJECTIVE: In this study, we investigated whether and how artificial intelligence chatbots facilitate the expression of user emotions, specifically sadness and depression. We also examined cultural differences in the expression of depressive moods among users in Western and Eastern countries.
METHODS: This study used SimSimi, a global open-domain social chatbot, to analyze 152,783 conversation utterances containing the terms "depress" and "sad" in 3 Western countries (Canada, the United Kingdom, and the United States) and 5 Eastern countries (Indonesia, India, Malaysia, the Philippines, and Thailand). Study 1 reports new findings on the cultural differences in how people talk about depression and sadness to chatbots based on Linguistic Inquiry and Word Count and n-gram analyses. In study 2, we classified chat conversations into predefined topics using semisupervised classification techniques to better understand the types of depressive moods prevalent in chats. We then identified the distinguishing features of chat-based depressive discourse data and the disparity between Eastern and Western users.
RESULTS: Our data revealed intriguing cultural differences. Chatbot users in Eastern countries indicated stronger emotions about depression than users in Western countries (positive: P
METHODS: The review follows a systematic methodology with four core components: eligibility criteria, review selection, data extraction, and data synthesis. Studies focused on AI applications and hybrid chatbots in healthcare, particularly in chronic disease management and mental health support, were included. Publications from 2022 to 2025 were prioritized, and peer-reviewed sources in English were considered. After screening 116 studies, 29 met the criteria for inclusion. Data was extracted using a structured template, capturing study objectives, methodologies, findings, and challenges. Thematic analysis was applied to identify four themes: AI applications, technical advancements, user adoption, and challenges/ethical concerns. Statistical and content analysis methods were employed to synthesize the data comprehensively, ensuring robustness in the findings.
RESULTS: Hybrid chatbots in healthcare have shown significant benefits, such as reducing hospital readmissions by up to 25%, improving patient engagement by 30%, and cutting consultation wait times by 15%. They are widely used for chronic disease management, mental health support, and patient education, demonstrating their efficiency in both developed and developing countries.
DISCUSSION: The review concludes that overcoming these barriers through infrastructure investment, training, and enhanced transparency is crucial for maximizing the potential of AI in healthcare. Future researchers should focus on long-term outcomes, addressing ethical considerations, and expanding cross-cultural adaptability. Limitations of the review include the narrow scope of some case studies and the absence of long-term data on AI's efficacy in diverse healthcare contexts. Further studies are needed to explore these challenges and the long-term impact of AI-driven healthcare solutions.